About the University
The University of Luxembourg aspires to be one of Europe’s most highly regarded universities with a distinctly international and interdisciplinary character .
It fosters the cross-fertilisation of research and teaching , is relevant to its country, is known worldwide for its research and teaching in targeted areas, and is establishing itself as an innovative model for contemporary European Higher Education.
It s core asset is its well-connected world-class academic staff which will attract the most motivated, talented and creative students and young researchers who will learn to enjoy taking up challenges and develop into visionary thinkers able to shape society.
Within the University, the Luxembourg Centre for Systems Biomedicine (LCSB) is a highly interdisciplinary research centre (IC), integrating experimental biology and computational biology approaches in order to develop the foundation of a future predictive, preventive and personalized medicine.
The Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg is a highly dynamic, multilingual and international working environment at campus Belval.
The Translational Neuroscience Group, led by Prof Rejko Krueger, creates a translational bridge between fundamental and the clinic with a focuse on Parkinson’s disease research, with the aim to improve diagnosis and therapy to help patients in Luxembourg and beyond.
We are currently looking for an energetic, highly motivated post-doctoral researcher for a collaborative fundamental biology research project in Parkinson’s Disease (PD).
Tasks / Activities
The post-doctoral researcher will contribute to relevant projects of the Translational Neuroscience Group, in particular to the investigation of the role of different models of α-syn pathogenicity in PD
The aim of this project is to characterize patient-based cellular models, e.g. using induced pluripotent stem cells to gain essential knowledge with respect to the molecular mechanisms involved in the pathogenesis of PD.
These models then will be explored for serving as cellular readouts for genetic and pharmacological modifications to revert disease associated phenotypes and to disentangle functional networks related to neurodegeneration.
Specific tasks can include :
Applications (in English) should contain the following documents :
Early application is highly encouraged, as the applications will be processed upon reception.